MSI2 is required for maintaining activated myelodysplastic syndrome stem cells
Several studies have recently demonstrated the role of the MSI2 RNA binding protein in normal and malignant haematopoietc stem cells. In this study, the authors show that MSI2 is required for maintaining myelodysplastic syndrome stem cells in mice and that MSI2 expression predicts poor prognosis in...
Saved in:
Main Authors: | James Taggart, Tzu-Chieh Ho, Elianna Amin, Haiming Xu, Trevor S. Barlowe, Alexendar R. Perez, Benjamin H. Durham, Patrick Tivnan, Rachel Okabe, Arthur Chow, Ly Vu, Sun Mi Park, Camila Prieto, Christopher Famulare, Minal Patel, Christopher J. Lengner, Amit Verma, Gail Roboz, Monica Guzman, Virginia M. Klimek, Omar Abdel-Wahab, Christina Leslie, Stephen D. Nimer, Michael G. Kharas |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/3c73f9725b9740dfbe30b10dcaac4d49 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Caribbean Msi+5 Regional Review
Published: (2015) -
Clonal evolution in myelodysplastic syndromes
by: Pedro da Silva-Coelho, et al.
Published: (2017) -
TP53 in Myelodysplastic Syndromes
by: Yan Jiang, et al.
Published: (2021) -
Managing myelodysplastic symptoms in elderly patients
by: R Ria, et al.
Published: (2009) -
The genomic landscape of pediatric myelodysplastic syndromes
by: Jason R. Schwartz, et al.
Published: (2017)